Extreme heterogeneity in CARD15 and DLG5 Crohn disease-associated polymorphisms between German and Norwegian populations

被引:37
作者
Medici, V
Mascheretti, S
Croucher, PJP
Stoll, M
Hampe, J
Grebe, J
Sturniolo, GC
Solberg, C
Jahnsen, J
Moum, B
Schreiber, S
Vatn, MH
机构
[1] Univ Kiel, Inst Clin Mol Biol, Dept Gen & Internal Med, D-24105 Kiel, Germany
[2] Padova Univ Hosp, Gastroenterol Sect, Dept Surg & Gastroenterol Sci, Padua, Italy
[3] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany
[4] Ullevaal Univ Hosp, Oslo, Norway
[5] Aker Univ Hosp, Oslo, Norway
[6] Univ Oslo, Rikshosp, IIF, Dept Med, N-0027 Oslo, Norway
关键词
Crohn disease; ulcerative colitis; NOD2; CARD15; DLG5; Norway;
D O I
10.1038/sj.ejhg.5201576
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The first gene associated with Crohn disease ( CD) has been identified as CARD15 (16q12). Three variants, R702W, G908R and 1007fsinsC are strongly and independently associated with the disease. A second gene, conveying a smaller risk for inflammatory bowel disease (IBD), has been identified as DLG5 (10q23). We assess the frequency of the CARD15 SNPs and of the R30Q mutation in DLG5 and their contribution to the development of CD in a cohort of unrelated IBD patients ( 151 CD, 325 ulcerative colitis (UC)) and healthy controls ( 236) from South-east Norway (IBSEN cohort). Genotype-based tests of population differentiation using 23 SNPs across CARD15, together with estimates of F-ST, indicated that the German and Norwegian background populations could be differentiated at the CARD15 locus. The Norwegian and German CD samples exhibited particularly strong differentiation at the three predisposing loci and those marking their background haplotype. There were significantly lower frequencies of the CARD15 SNPs and no significant association with CD in the Norwegian samples. Only a marginal association was observed for the subphenotypes ileitis and ileocolitis vs colitis ( P = 0.048). The population attributable risk percentage ( PAR%) for CARD15 variants in the Norwegian cohort is the lowest reported for a European population ( 1.88%), except Iceland. Similarly, the DLG5 variant showed no association with CD or IBD, however, there was a negative correlation with stricture ( P = 0.035). The present results are consistent with an emerging pattern of a low frequency of the CARD15 variants in Northern countries where the prevalence of IBD is greatest.
引用
收藏
页码:459 / 468
页数:10
相关论文
共 50 条
[1]   Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease [J].
Abreu, MT ;
Taylor, KD ;
Lin, YC ;
Hang, T ;
Gaiennie, J ;
Landers, CJ ;
Vasiliauskas, EA ;
Kam, LY ;
Rojany, M ;
Papadakis, KA ;
Rotter, JI ;
Targan, SR ;
Yang, HY .
GASTROENTEROLOGY, 2002, 123 (03) :679-688
[2]   The molecular classification of the clinical manifestations of Crohn's disease [J].
Ahmad, T ;
Armuzzi, A ;
Bunce, M ;
Mulcahy-Hawes, K ;
Marshall, SE ;
Orchard, TR ;
Crawshaw, J ;
Large, O ;
De Silva, A ;
Cook, JT ;
Barnardo, M ;
Cullen, S ;
Welsh, KI ;
Jewell, DP .
GASTROENTEROLOGY, 2002, 122 (04) :854-866
[3]   Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy -: An Italian Group for Inflammatory Bowel Disease Study [J].
Annese, V ;
Palmieri, O ;
Latiano, A ;
Ardizzone, S ;
Castiglione, F ;
Cottone, M ;
D'Incà, R ;
Gionchetti, P ;
Papi, C ;
Riegler, G ;
Vecchi, M ;
Andriulli, A .
DIGESTIVE AND LIVER DISEASE, 2004, 36 (02) :121-124
[4]   NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? [J].
Arnott, IDR ;
Nimmo, ER ;
Drummond, HE ;
Fennell, J ;
Smith, BRK ;
MacKinlay, E ;
Morecroft, J ;
Anderson, N ;
Kelleher, D ;
O'Sullivan, M ;
McManus, R ;
Satsangi, J .
GENES AND IMMUNITY, 2004, 5 (05) :417-425
[5]   Association of NOD2 with Crohn's disease in a homogenous Irish population [J].
Bairead, E ;
Harmon, DL ;
Curtis, AM ;
Kelly, Y ;
O'Leary, C ;
Gardner, M ;
Leahy, DT ;
Vaughan, P ;
Keegan, D ;
O'Morain, C ;
O'Donoghue, D ;
Shanahan, F ;
Parfrey, NA ;
Quane, KA .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2003, 11 (03) :237-244
[6]   Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan [J].
Bonen, DK ;
Ogura, Y ;
Nicolae, DL ;
Inohara, N ;
Saab, L ;
Tanabe, T ;
Chen, FF ;
Foster, SJ ;
Duerr, RH ;
Brant, SR ;
Cho, JH ;
Nuñez, G .
GASTROENTEROLOGY, 2003, 124 (01) :140-146
[7]   The Nod2 gene in Crohn's disease: Implications for future research into the genetics and immunology of Crohn's disease [J].
Cho, JH .
INFLAMMATORY BOWEL DISEASES, 2001, 7 (03) :271-275
[8]   Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations [J].
Croucher, PJP ;
Mascheretti, S ;
Hampe, J ;
Huse, K ;
Frenzel, H ;
Stoll, M ;
Lu, T ;
Nikolaus, S ;
Yang, SK ;
Krawczak, M ;
Kim, WH ;
Schreiber, S .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2003, 11 (01) :6-16
[9]   The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease [J].
Cuthbert, AP ;
Fisher, SA ;
Mirza, MM ;
King, K ;
Hampe, J ;
Croucher, PJP ;
Mascheretti, S ;
Sanderson, J ;
Forbes, A ;
Mansfield, J ;
Schreiber, S ;
Lewis, CM ;
Mathew, CG .
GASTROENTEROLOGY, 2002, 122 (04) :867-874
[10]   Association of DLG5 R30Q variant with inflammatory bowel disease [J].
Daly, MJ ;
Pearce, AV ;
Farwell, L ;
Fisher, SA ;
Latiano, A ;
Prescott, NJ ;
Forbes, A ;
Mansfield, J ;
Sanderson, J ;
Langelier, D ;
Cohen, A ;
Bitton, A ;
Wild, G ;
Lewis, CM ;
Annese, V ;
Mathew, CG ;
Rioux, JD .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2005, 13 (07) :835-839